Evidence map›Paper›PMID 42350413›Full record

ArticleNature communications2026

Author Correction: ATF7IP/SETDB1-mediated epigenetic programming regulates thymic homing and T lymphopoiesis of hematopoietic progenitors during embryogenesis.

Wenqi Chen, Jiaxin Wu, Peilu She, Juan Li, Yuying Lan, Xueli Hu, Yangguo Huangfu, Chen Wu, Daqing Jin, Peng Xie and 6 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Wenqi Chen *Shanghai Key Laboratory of Regulatory Biology, Shanghai Frontier Science Center of Genome Editing and Cell Therapy, East China Normal University School of Life Sciences, Shanghai, China.ORCID https://orcid.org/0000-0001-8057-4378
Jiaxin Wu *Shanghai Key Laboratory of Regulatory Biology, Shanghai Frontier Science Center of Genome Editing and Cell Therapy, East China Normal University School of Life Sciences, Shanghai, China.
Peilu She *Shanghai Key Laboratory of Regulatory Biology, Shanghai Frontier Science Center of Genome Editing and Cell Therapy, East China Normal University School of Life Sciences, Shanghai, China.ORCID https://orcid.org/0009-0001-1772-4414
Juan Li *Shanghai Key Laboratory of Regulatory Biology, Shanghai Frontier Science Center of Genome Editing and Cell Therapy, East China Normal University School of Life Sciences, Shanghai, China.
Yuying LanShanghai Key Laboratory of Regulatory Biology, Shanghai Frontier Science Center of Genome Editing and Cell Therapy, East China Normal University School of Life Sciences, Shanghai, China.
Xueli HuShanghai Key Laboratory of Regulatory Biology, Shanghai Frontier Science Center of Genome Editing and Cell Therapy, East China Normal University School of Life Sciences, Shanghai, China.
Yangguo HuangfuShanghai Key Laboratory of Regulatory Biology, Shanghai Frontier Science Center of Genome Editing and Cell Therapy, East China Normal University School of Life Sciences, Shanghai, China.
Chen WuSEU-ALLEN Joint Center, Institute for Brain and Intelligence, Southeast University, Nanjing, China.
Daqing JinShanghai Key Laboratory of Regulatory Biology, Shanghai Frontier Science Center of Genome Editing and Cell Therapy, East China Normal University School of Life Sciences, Shanghai, China.
Peng XieSEU-ALLEN Joint Center, Institute for Brain and Intelligence, Southeast University, Nanjing, China.ORCID https://orcid.org/0000-0002-9509-7268
Guanglei ZhuangShanghai Key Laboratory of Gynecologic Oncology, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yuxuan WuShanghai Key Laboratory of Regulatory Biology, Shanghai Frontier Science Center of Genome Editing and Cell Therapy, East China Normal University School of Life Sciences, Shanghai, China.ORCID https://orcid.org/0000-0002-9155-9883
Yiyue ZhangDivision of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology, Guangzhou, China.ORCID https://orcid.org/0000-0002-9402-3523
Leonard I ZonStem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA, USA.ORCID https://orcid.org/0000-0003-0860-926X
Ping ZhuGuangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. tanganqier@163.com.ORCID https://orcid.org/0000-0002-4276-9593
Tao P ZhongShanghai Key Laboratory of Regulatory Biology, Shanghai Frontier Science Center of Genome Editing and Cell Therapy, East China Normal University School of Life Sciences, Shanghai, China. tzhong@bio.ecnu.edu.cn.ORCID https://orcid.org/0000-0003-1159-5487

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42350413
PMCPMC13303878

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.